Related Experiment Video
Updated: Sep 2, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Endothelial dysfunction in children with type 1 diabetes mellitus
Mariapina Pomilio1, Angelika Mohn, Alberto Verrotti
1Clinica Pediatrica, University of Chieti, Italy.
Insights
Endothelial dysfunction, a loss of normal cell properties, is linked to diabetic vascular complications. Impaired vasodilatation is a sensitive marker in type 1 diabetes mellitus patients.
Area of Science:
- Vascular Biology
- Endocrinology
- Diabetology
Background:
- Endothelial dysfunction involves the loss of normal endothelium functions, impacting vascular tone, permeability, and coagulation.
- Unbalanced glycaemic control in type 1 diabetes mellitus (DM) significantly affects the endothelium, contributing to vascular complications.
- Endothelial cell activation markers and impaired endothelium-dependent vasodilatation are observed in young type 1 DM patients.
Purpose of the Study:
- To investigate the role of endothelial dysfunction in the pathogenesis of vascular complications in type 1 DM.
- To identify sensitive markers for early endothelial involvement in diabetic patients.
- To understand the pathophysiological mechanisms linking hyperglycemia to endothelial dysfunction.
Main Methods:
- Assessing endothelium-derived regulatory proteins, such as von Willebrand factor (vWF) and tissue plasminogen activator (t-PA).
- Evaluating endothelium-dependent vasodilatation as a marker of endothelial function.
- Analyzing the impact of hyperglycemia on endothelial cell functions and metabolic pathways.
Main Results:
- Endothelial dysfunction is characterized by altered protein synthesis, increased vascular tone/permeability, and prothrombotic/antifibrinolytic properties.
- Abnormal markers of endothelial activation and impaired endothelium-dependent vasodilatation are evident in young type 1 DM patients.
- Hyperglycemia directly or indirectly alters endothelium functions through various metabolic pathways.
Conclusions:
- Endothelial dysfunction is a critical factor in diabetic vascular complications, particularly in type 1 DM.
- Impaired endothelium-dependent vasodilatation may serve as a more sensitive indicator of early endothelial damage than specific protein markers.
- A comprehensive understanding of endothelial dysfunction pathophysiology is crucial for developing timely therapeutic interventions to prevent or slow diabetic complications.
Abstract:
Endothelial dysfunction is defined as the loss of endothelium properties, e.g. alteration of protein synthesis, increased vascular tone and permeability, acquisition of prothrombotic and antifibrinolytic properties. Endothelium, a primary target of unbalanced glycaemic control, is involved in the pathogenesis of vascular complications in patients with type 1 diabetes mellitus (DM). Vascular endothelium damage is characterised by an increase of endothelium-derived regulatory proteins. vWF and t-PA may be useful to investigate early endothelium involvement. However, impaired endothelium-dependent vasodilatation may be a more sensitive marker. Abnormal markers of endothelial cell activation and impaired endothelium-dependent vasodilatation have been observed in young patients with type I DM. Hyperglycaemia may alter normal endothelium functions, either directly or indirectly, by inducing different metabolic pathways. Complete understanding of the pathophysiology of endothelial dysfunction may lead to timely therapeutic intervention to prevent its development and to slow the progression of diabetic complications.
More Related Videos
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
14:10A Microfluidic System for Modeling Endothelial Dysfunction under Combined Physiological Pulsatile Shear Stress and Oscillatory Hyperglycemia
Published on: May 12, 2026
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Diabetic Retinopathy
Diabetic Nephropathy